PortfoliosLab logoPortfoliosLab logo
FOJCY vs. BMY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FOJCY vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fortum Oyj ADR (FOJCY) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FOJCY achieves a 3.51% return, which is significantly lower than BMY's 25.17% return. Over the past 10 years, FOJCY has outperformed BMY with an annualized return of 11.94%, while BMY has yielded a comparatively lower 2.16% annualized return.


FOJCY

1D
-1.58%
1M
-2.89%
6M
-7.31%
YTD
3.51%
1Y
19.66%
3Y*
30.66%
5Y*
2.71%
10Y*
11.94%
ALL TIME*
8.33%

BMY

1D
0.69%
1M
12.35%
6M
21.21%
YTD
25.17%
1Y
54.75%
3Y*
6.92%
5Y*
3.38%
10Y*
2.16%
ALL TIME*
9.43%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$711.50M$665.03M$681.59M
$34.03K$32.87K$39.10K

FOJCY vs. BMY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FOJCY
Fortum Oyj ADR
3.51%79.68%2.92%-5.53%-44.41%40.46%3.42%29.28%13.34%56.58%
BMY
Bristol-Myers Squibb Company
25.17%0.11%15.81%-26.14%18.98%2.88%0.41%27.74%-12.90%7.71%

Correlation

The correlation between FOJCY and BMY is 0.00, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.00

Correlation (3Y)
Balances recent behavior with more history.

0.05

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.06

Correlation (10Y)
Provides a long-term view across more market conditions.

0.08

Correlation (All Time)
Calculated using the full available price history since May 5, 2009

0.10

Fundamentals

Market Cap

FOJCY:

$98.03B

BMY:

$133.37B

EPS

FOJCY:

€0.18

BMY:

$4.54

PE Ratio

FOJCY:

20.54

BMY:

14.37

PS Ratio

FOJCY:

3.10

BMY:

2.71

PB Ratio

FOJCY:

2.09

BMY:

5.99

Total Revenue (TTM)

FOJCY:

€5.49B

BMY:

$49.19B

Gross Profit (TTM)

FOJCY:

€1.99B

BMY:

$34.51B

EBITDA (TTM)

FOJCY:

€1.49B

BMY:

$16.67B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FOJCY vs. BMY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FOJCY
FOJCY Risk / Return Rank: 6565
Overall Rank
FOJCY Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
FOJCY Sortino Ratio Rank: 6060
Sortino Ratio Rank
FOJCY Omega Ratio Rank: 5858
Omega Ratio Rank
FOJCY Calmar Ratio Rank: 7171
Calmar Ratio Rank
FOJCY Martin Ratio Rank: 7171
Martin Ratio Rank

BMY
BMY Risk / Return Rank: 9292
Overall Rank
BMY Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
BMY Sortino Ratio Rank: 9393
Sortino Ratio Rank
BMY Omega Ratio Rank: 9090
Omega Ratio Rank
BMY Calmar Ratio Rank: 9494
Calmar Ratio Rank
BMY Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FOJCY vs. BMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fortum Oyj ADR (FOJCY) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FOJCYBMYDifference
Sharpe ratioReturn per unit of total volatility

-1.60

Sortino ratioReturn per unit of downside risk

-2.02

Omega ratioGain probability vs. loss probability

1.12

1.36

-0.24

Calmar ratioReturn relative to maximum drawdown

1.32

4.66

-3.33

Martin ratioReturn relative to average drawdown

3.04

11.09

-8.05

FOJCY vs. BMY - Sharpe Ratio Comparison

The current FOJCY Sharpe Ratio is 0.54, which is lower than the BMY Sharpe Ratio of 2.14. The chart below compares the historical Sharpe Ratios of FOJCY and BMY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FOJCY vs. BMY - Drawdown Comparison

The maximum FOJCY drawdown since its inception was -70.67%, roughly equal to the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for FOJCY and BMY.


Loading charts...

Drawdown Indicators


FOJCYBMYDifference

Max Drawdown

Largest peak-to-trough decline

-70.67%

-72.03%

+1.36%

Max Drawdown (1Y)

Largest decline over 1 year

-18.79%

-12.53%

-6.26%

Max Drawdown (3Y)

Largest decline over 3 years

-25.89%

-34.11%

+8.22%

Max Drawdown (5Y)

Largest decline over 5 years

-70.67%

-47.67%

-23.00%

Max Drawdown (10Y)

Largest decline over 10 years

-70.67%

-47.67%

-23.00%

Current Drawdown

Current decline from peak

-17.08%

-4.95%

-12.13%

Average Drawdown

Average peak-to-trough decline

-24.91%

-22.36%

-2.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.18%

5.25%

+2.93%

Volatility

FOJCY vs. BMY - Volatility Comparison

Fortum Oyj ADR (FOJCY) has a higher volatility of 10.80% compared to Bristol-Myers Squibb Company (BMY) at 9.10%. This indicates that FOJCY's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FOJCYBMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.80%

9.10%

+1.70%

Volatility (6M)

Calculated over the trailing 6-month period

34.06%

19.64%

+14.42%

Volatility (1Y)

Calculated over the trailing 1-year period

45.85%

27.86%

+17.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.77%

24.49%

+24.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.28%

25.46%

+16.82%

Dividends

FOJCY vs. BMY - Dividend Comparison

FOJCY's dividend yield for the trailing twelve months is around 3.90%, more than BMY's 3.84% yield.


PositionTTM20252024202320222021202020192018201720162015
BMY
Bristol-Myers Squibb Company
3.84%4.60%4.24%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%
FOJCY
Fortum Oyj ADR
3.90%6.94%9.39%6.74%7.57%4.22%7.37%4.88%6.47%11.86%16.86%9.06%

Financials

FOJCY vs. BMY - Financials Comparison

This section allows you to compare key financial metrics between Fortum Oyj ADR and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

FOJCY vs. BMY - Profitability Comparison

The chart below illustrates the profitability comparison between Fortum Oyj ADR and Bristol-Myers Squibb Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

FOJCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Fortum Oyj ADR reported a gross profit of 400.00M and revenue of 1.12B. Therefore, the gross margin over that period was 35.6%.

BMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported a gross profit of 9.25B and revenue of 12.97B. Therefore, the gross margin over that period was 71.3%.

FOJCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Fortum Oyj ADR reported an operating income of 107.00M and revenue of 1.12B, resulting in an operating margin of 9.5%.

BMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported an operating income of 4.09B and revenue of 12.97B, resulting in an operating margin of 31.5%.

FOJCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Fortum Oyj ADR reported a net income of 109.00M and revenue of 1.12B, resulting in a net margin of 9.7%.

BMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported a net income of 3.32B and revenue of 12.97B, resulting in a net margin of 25.6%.


Frequently Asked Questions


FOJCY and BMY have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FOJCY has higher volatility (10.80%) compared to BMY (9.10%). In terms of maximum drawdown, FOJCY dropped -70.67% vs BMY's -72.03%.

BMY currently has the higher Sharpe Ratio (2.14 vs 0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FOJCY and BMY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer